Announcements Trials

Browse Landscape

Phase

Phase 2 2 Phase 3 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Sarcoma 1 Osteosarcoma 1

Interventions

Specimen Handling 149 pembrolizumab 123 Magnetic Resonance Spectroscopy 120 Cyclophosphamide 115 Biopsy 98 fludarabine 90 Nivolumab 53 Carboplatin 53 Cisplatin 48 Gemcitabine 46 Radiotherapy 41 venetoclax 40 fludarabine phosphate 40 Paclitaxel 40 Cetuximab 40 Ipilimumab 34 atezolizumab 33 Fluorouracil 33 Bevacizumab 33 Oxaliplatin 27 Leucovorin 27 X-Rays 26 Dexamethasone 26 durvalumab 25 Irinotecan 25 Radiation 24 Cytarabine 24 Azacitidine 24 Injections 23 Pemetrexed 21

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Pafolacianine × 90 days × Clear all

NCT06235125 2026-06-05

Cytalux

Ann & Robert H Lurie Children's Hospital of Chicago

Phase 1 Recruiting

Sarcoma, Osteosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡